Pular para o conteúdo

Interações medicamentosas

Lonafarnib + Lorlatinib

Gravidade: Contraindicada

Lonafarnib and Lorlatinib: contraindicated interaction.

Última atualização

Para profissionais de saúde — apenas referência. Esta página é um resumo breve, não é aconselhamento médico nem substitui a bula oficial ou o julgamento clínico. Verifique sempre antes de prescrever ou dispensar.

O conteúdo clínico desta página está disponível apenas em inglês.

Resumo

Lorlatinib induces CYP3A4, and lonafarnib is a sensitive CYP3A4 substrate. Lowered lonafarnib exposure may reduce its benefit, and labeling contraindicates its use with CYP3A inducers.

O que esta interação significa em palavras simples

Lonafarnib and Lorlatinib are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Lonafarnib belongs to Miscellaneous; Lorlatinib belongs to Oncology.

Nível de evidência: Moderate

Por que acontece

Lorlatinib induces CYP3A4 and speeds lonafarnib metabolism.

O que fazer

Avoid the combination and consider an alternative to lorlatinib. Seek specialist advice if both are essential.

O que perguntar ao farmacêutico

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Para assinantes do Pro+

Desbloqueie a página completa

Crie uma conta e comece um teste do Pro+ para desbloquear a orientação completa de conduta para Lonafarnib e Lorlatinib, as notas adicionais, os detalhes da evidência e o verificador de interações para uma prescrição completa.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Experimente o Pro+ grátis por 14 dias na web. Sem cartão.

Perguntas frequentes

Can I take Lonafarnib with Lorlatinib?

MediHelp rates the interaction as contraindicated. Lonafarnib and Lorlatinib are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Lorlatinib induces CYP3A4, and lonafarnib is a sensitive CYP3A4 substrate. Lowered lonafarnib exposure may reduce its benefit, and labeling contraindicates its use with CYP3A inducers.

How serious is the interaction between Lonafarnib and Lorlatinib?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination and consider an alternative to lorlatinib. Seek specialist advice if both are essential.

What other medicines interact with Lorlatinib?

MediHelp also lists interactions of Lorlatinib with, for example, Amobarbital, Apalutamide, Butabarbital. The full list is on the Lorlatinib page.

Monografias completas, posologia e verificador de interações no app MediHelp

Abra a referência completa, verifique interações entre vários medicamentos e use as ferramentas de posologia no app MediHelp.

Explorar de A a Z · Interações medicamentosas

Baixar o app Entrar